High Q Technologies and Creative Biostructure Announce Strategic Partnership Expanding Global Access to Quantum-Enabled EPR Spectroscopy

Contributed by: Business Wire

Tags

Research
FDA
Clinical Trials
Biotechnology
Radiology
Health
Pharmaceutical
General Health
Science
High Q Technologies and Creative Biostructure Announce Strategic Partnership

More Like This

QPS Netherlands High Resolution Mass Spectrometry Laboratory in Groningen, The Netherlands. (Photo: Business Wire)

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development

EDT device (Photo: Business Wire)

Rigaku: Novel Electron Density Topography Technology to Reveal Biological Macromolecules’ Properties

Zamas Lam, PhD, Global Head of Bioanalytical (Mass Spec) & Preclinical Development, QPS LLC. (Photo: Business Wire)

QPS Significantly Enhances Mass Spectrometry Laboratory Capacity

Daniel Schulz-Jander, QPS Senior Director, Bioanalysis

Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis

PR Newswire associated0

Tetra Pharm Technologies and Kvantify Announce Partnership to Accelerate the Discovery of Novel Drug Candidates Targeting the Endocannabinoid System

Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress

New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

PR Newswire associated0

Historic Cavendish Laboratory and FormationQ Launch Applied Quantum Program Using IonQ's Technology Platform